Aberdeen Group
EVH icon

Aberdeen Group’s Evolent Health EVH Stock Holding History

Aberdeen Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,146,329
Closed -$11.6M – 931
2020
Q1 		$11.6M Sell
2,146,329
-78,331
-4% -$700K 0.04% 368
2019
Q4 		$20.1M Buy
2,224,660
+159
+0% +$1.29K 0.05% 328
2019
Q3 		$16M Buy
2,224,501
+32,429
+1% +$233K 0.04% 360
2019
Q2 		$17.4M Buy
2,192,072
+10,821
+0.5% +$128K 0.04% 387
2019
Q1 		$27.4M Buy
2,181,251
+75,483
+4% +$1.2M 0.06% 294
2018
Q4 		$40.9M Buy
2,105,768
+234,225
+13% +$5.42M 0.1% 185
2018
Q3 		$53.1M Buy
1,871,543
+401,893
+27% +$9.59M 0.1% 192
2018
Q2 		$31M Buy
1,469,650
+360,206
+32% +$6.82M 0.06% 297
2018
Q1 		$15.8M Buy
1,109,444
+23,876
+2% +$342K 0.03% 386
2017
Q4 		$13.4M Buy
+1,085,568
New +$15.3M 0.03% 420

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Aberdeen Group's EVH Position: Q2 2020 in Review

Aberdeen Group sold out of Evolent Health (EVH) in Q2 2020, closing a stake of 2,146,329 shares — an estimated $11.6M sold.

Aberdeen Group first reported a position in EVH in Q4 2017 and held it in 10 quarters. The position peaked at $53.1M in Q3 2018. 136 funds tracked by Wall St. Rank hold EVH as of Q2 2020.

  • Aberdeen Group reported no remaining Evolent Health position as of Q2 2020 after selling out during the quarter.
  • Aberdeen Group sold 2,146,329 Evolent Health shares in Q2 2020, an estimated $11.6M.
  • Aberdeen Group first reported a position in Evolent Health in Q4 2017 and held it in 10 quarters.
  • Aberdeen Group's Evolent Health position peaked at $53.1M in Q3 2018.
  • 136 funds tracked by Wall St. Rank held Evolent Health as of Q2 2020.

Based on Aberdeen Group's 13F filing for Q2 2020, filed 10 Aug 2020.